Mon, Nov 24, 2014, 4:48 AM EST - U.S. Markets open in 4 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

LG Display Co., Ltd. Message Board

rchites 923 posts  |  Last Activity: Nov 21, 2014 4:21 PM Member since: Apr 12, 2004
  • Reply to

    BEAR RAIDS TOMMOROW ... SELL IMMEDIATELY...

    by tigastiti372 Nov 2, 2014 5:47 PM
    rchites rchites Nov 2, 2014 6:21 PM Flag

    you will be lucky to get out with your shirt. These hedge funds flip on the dime. They see the no ICON patents , PFE, Hunters past, Gates press, SEC, AMGEN having problems, SGK agreements in the making with Texas A&M/Caliber/IBIO. They also know ZMapp has contacted NOVICI were Robert is Chairman. ITS all lies about IBIO and Robert is getting the upper hand before the 10th of NOVEMBER. GOODBUY shorty

  • Watch for an official PFE PR late in the week on Thursday or Friday forecasts Sierra. BIDDING war for IBIO may be between PFE , AMGEN and GSK. GSK has ties to Texas A & M who will most likely manufacture the plant ZMapp. Press came out Saturday on speculation the media will get the real release later in the week with PFE. AMGEN makes the animal ZMAPP that has to over come obstacles making it. They may want the platform for other drugs in MAPPS pipeline in the USA. They see the future of ICON not having US. the press is pressing shorts to flip. They are well aware of the lies and deceptions. Melissa has played this game many times and its HUNTERS second time raiding this stock.

  • rchites rchites Nov 2, 2014 6:04 PM Flag

    They all should be wanting to get into plantibodies. GSK should jump with TEXAS A & M partnership. We will be in the money soon as the press is mounting going into November. We could even see a Amgen take out bid. Amgen is trying to make ZM IT running into a lot of trouble as the antibodies are not growing fast enough in animals. DDDaaaa Robert was right all along. Shorts will be going long with options soon and nobody will sell ......

  • rchites rchites Nov 2, 2014 5:58 PM Flag

    The habeen pulling my post also. It wouldn't have any thing to do with Melisa being a contributing editor to YAHOO could it. YAHOO post theSTREET Hit-pieces. ALPH

  • rchites by rchites Nov 2, 2014 2:14 PM Flag

    Its a crime if the government don't back GATES, Zuch, Allen and his efforts. ITS what smaller companies like IBIO are all about...Being innovative, disruptive, and nimble. .... ROBERT was not taking advantage of the Ebola situation. He was doing what the company was designed for. Cheaper , faster , better drugs in emergencies. GATES knows and backs IBIO. In the 10k I read about the government and Anthrax , a whole business segment . Ebola defiantly fits their description. They have a defense segment for such out breaks or diseases used as a weapon. The government has departments for out breaks and programs (((( BARDA))))) ... Lets see Melissa go after Texas A & M. GSK or Emergent. Its not a crime or bad ethics to help when your company is dedicated to solutions, diseases and life saving methods. The only peace of mind we may get is to know we are on the GATES side. I think he is going in the right direction.

  • rchites rchites Nov 2, 2014 2:03 PM Flag

    much more then EBOLA.............. ITS the DOORS opening for a lot more testing of other drugs. GETTING press is a must. Big companies us the old methods and pass the cost to customers and stock holders. Utilizing big expensive equipment and justifying it to defense and government agencies. IBIO / ICON /Caliber represent change. IT is a lot bigger. YOU may have big manufactures, Gambino's, manipulators, in the blog next to you.............

  • rchites rchites Nov 2, 2014 1:58 PM Flag

    The need for an unclogged research pipeline is a refrain from Gates, the humanitarian technologist. It is the task of innovation to stay ahead of evolutionary biology — the mutations that make diseases more deadly, easier to transmit, or more resistant to treatment...................... GATES is really in an uphill battle ........... On one hand you have traditional methods with animals with huge corporations like AMGIN ( incidentally is up for ebola animal ZMAP) ad new treatments like Mapp plant tobacco cocktail ZMapp. IBIOs platform helps companies with plantibodies and GATES understands the new platform. His role could be crucial for good press. The technology is there as ICON/ZMapp first vaccine was a hit. Other vaccines and cures are coming as a GATES /IBIO is in testing. FASTER

  • rchites rchites Nov 2, 2014 9:41 AM Flag

    https://tts.sec.gov/oiea/QuestionsAndComments.html

  • Reply to

    PUT 3 and 4 dollar sells on your stock.

    by rchites Nov 2, 2014 8:47 AM
    rchites rchites Nov 2, 2014 9:34 AM Flag

    My broker wont let me go up above 300% profit Some kind of control for bad orders or some thing. the world has to see the LIES of ADAM and MELISSA. They made a huge deal over the financing of 10 million shares when the average daily trading was 11 million. Then the 10 million was over a 2 year period. I REMEMBER ONE DAY IT TRADED 60 MILLION IN A DAY. That's how they distort and twist things. tHE WOORST PART WS THE EMPHASIS ON drug . Adam made a huge deal over one small part of the company and made it seam like that was all the company had going. (sic) . The huge markets for these drugs is very meaningful and large. I do have a big position for myself and its part of my retirement plan. I am sure many others have seen their retirement money hut by these fraudsters.

  • You can raise them later in the squeeze. Make it so they can not borrow your shares. I have been doubling down and I am as mad as any body about her lies.

  • Reply to

    Caliber Doesn't Own ZMAPP!!

    by rhmystic Nov 1, 2014 8:59 AM
    rchites rchites Nov 1, 2014 9:33 AM Flag

    HE IS mad because Kentucky CAN ONLY PRODUCE 20 DOSES A MONTH. THEN come to find out ICON patents cant be used to produce in the USA. He is coming to realize IBIO does have patents and discoveries in the last few years that ICON and MAPP will use. He is waking up to the accolades of the board, president , company and footprint in the industry. SO you have a drug maker who cant ramp /produce for the government and have no rights to produce plantibodies . ZMAPP is also making ZMAPP with animal cells that ran into reproduction problems.... THESE PRODUCTS are well described as benefits of IBIO. The animal antibodies are not growing very good. The company said ((( lately)))) they will just have to over come that in one of the three drugs in the cocktail. rhmystic is having a rough week. The BARDA program will bail them out with the much needed steps the company and shorts and sweepers swept under the rug. TEXAS A& M CALIBER and IBIO. ANOTHER manufacturer contacted by the BARDA program and TASK ORDER said they are looking for a manufacturer........... Maybe they found CALIBER was booked by TEASAS A & M..... Nobody left?

  • Reply to

    Caliber Doesn't Own ZMAPP!!

    by rhmystic Nov 1, 2014 8:59 AM
    rchites rchites Nov 1, 2014 9:15 AM Flag

    IBIO works with the people MAPP must use to manufacture ZMAPP. ZMAPP don't own patents or ICON to manufacture in America according to news. . According to news Melisa is to stupid to know EBOLA is a DISEASE and triggers defense spending to defense companies. You and Melissa are to stupid to think a PLATFORM is a products ............. I bet most people understand slow periods for vaccine makers and designers. THEN PEEK during outbreaks and new PANICS. SEE if you are smart enough to see the PRESS all over the web about ____________DESEASES______We are a biotechnology company focused on commercializing our proprietary platform technologies, the iBioLaunch(TM) platform for vaccines and therapeutic proteins and the iBioModulator(TM) platform for vaccine enhancement and on developing and commercializing select product candidates derived from the iBioLaunch platform.

  • rchites rchites Nov 1, 2014 9:04 AM Flag

    brazil , 3 plants in china , Europe and global with GE. YOUR momma failed to have a kid with a brain.......Why is Melissa to stupid to see a defense contractor get Ebola work? PLEASE ask that nit wit if EBOLA is a disease because IBIO works with diseases and its published every where.

  • rchites rchites Nov 1, 2014 9:00 AM Flag

    GE is taking their technology across the globe. liar

  • rchites rchites Nov 1, 2014 8:50 AM Flag

    You remind of that brain dead short that shorted LAKE and GOPRO the other day before they sky rocketed...... The government ordered like a million suits............... to funny........ Is Mellissa to stupid to think a defense company with a subsidiary in defense would not act in the case of national security or an out break.... Ebola is listed as a possible weapon.......... Melissa is a liar and twist words to her advantage. You remind me of her with out writing skills. IT like """ no role""" ""NOTHING""" when you are looking at a pipeline and testing's. DO you understand NOVICI, Caliber, and what a platform does.............. MELISSA don't.......... SHE don't think a ((((( platform ))))) can be used for defense purposes or on EBOLA.............. IT cant be used because it wasn't on their 10k or Qs............ Is she to stupid to call these guys , look at their web page, look at the companies description on 50 financial web sites... IM sure she never seen a one of those.

  • rchites rchites Nov 1, 2014 8:37 AM Flag

    Hey brain-dead.... They developed a kick butz platform............ But you have to be smarter then a 5 year old to know who GE is ................ I bet you don't understand what a platform and applications are????? • Ibio, working with Fraunhofer Center for Molecular Biotechnology, developed a plant-based technology called iBioLaunch that can bring vaccines to market more rapidly. YOU are as stupid as Melissa...... She is the only person dumb enough not to include EBOLA as a defense weapon or something that needs a vaccine ..... The company states the work on defence issues and vaccines for defense and private parties........... IT is out side her 5 the grade logic not in include many diseases.....

  • rchites rchites Oct 31, 2014 4:08 PM Flag

    IT was a fair article. Showed both sides. I wish it would have said more about barda and AMGENs" problem with ramping EBOLA animal cells ZMAPP. The antibodies are not growing well with animal cells. Plant antibodies grow much faster and easier. Will this impact the BARD decision? It has to some degree. I think they will produce animal and cell ZMAPP. his put a greater emphasis on plants and Caliber......... The piece just said it is a hurdle they have to over come.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Robert was right again.

  • Reply to

    Johnson and Johnson Also has a Drug.

    by rhmystic Oct 31, 2014 3:16 PM
    rchites rchites Oct 31, 2014 3:56 PM Flag

    Many have animal based cures.... Not ebola but general virus drugs //////// NONE TESTED..... ITS a good way to get rid of the old virus drugs that wont work.... THE press has stated no drugs have been tested on humans up until recently. ITS funny how these animal based hard and slow to make drugs have been popping up occasionally..... NO human testing and many haven't ben tested on animals at all. BOY and Melissa thinks IBIO pumped up and hyped a drug and took advantage of ebola.... SHE thinkls IBIO is the only one to co0me up with a drug or solution. She is delusional.

  • Reply to

    Added 8,295 shares @ 1.04 .....

    by ambo_988 Oct 31, 2014 3:39 PM
    rchites rchites Oct 31, 2014 3:50 PM Flag

    welcome aboard. Many of us have loaded again lately.

  • Reply to

    NO Assurance Caliber Will Get The Contract!!

    by rhmystic Oct 31, 2014 3:06 PM
    rchites rchites Oct 31, 2014 3:49 PM Flag

    ITS THE BIGGEST and best for plantibodies. ACTUALY its the only move ..... Its a no brainer..... So you have no brain posting that #$%$..... Who else???? Answer r go home mad/

LPL
15.80+0.19(+1.22%)Nov 21 4:07 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.